Executive Summary:
These notifications from the Ministry of Finance, Department of Revenue, declare specific substances, salts, and preparations as manufactured drugs and amend the list of psychotropic substances. The notifications, S.O. 1350(E), S.O. 1351(E) and S.O. 1352(E) were issued on March 13, 2019, under the authority of the Narcotic Drugs and Psychotropic Substances Act, 1985.
Key Points / Main Content:
Manufactured Drugs Declaration (S.O. 1350(E)):
* The Central Government declares the following substances, salts, and preparations to be manufactured drugs:
* Carfentanil
* Ocfentanil
* Furanylfentanyl
* Acryloylfentanyl (Acrylfentanyl)
* 4-Fluoroisobutyrfentanyl
* Tetrahydrofuranylfentanyl
Amendment to Notification S.O. 1055(E) (S.O. 1351(E)):
* Further amends notification S.O. 1055(E) of the Government of India, Ministry of Finance, Department of Revenue, published on October 19, 2001.
* Inserts the following substances into the table of narcotic drugs and psychotropic substances, specifying their chemical name, other non-proprietary names, small commercial quantity, and quantity in gm. and kg.:
* Carfentanil
* Ocfentanil
* Furanylfentanyl
* Acryloylfentanyl (Acrrylfentanyl)
* 4-Fluoroisobutyrfentanyl (4FIBF, pFIBF)
* Tetrahydrofuranylfentanyl (THF)
* AB-CHMINACA
* 5F-ADB (5F-MDMB-PINACA)
* AB-PINACA
* UR-144
* 5F-PB22
* 4-Fluoroamphetamine (4FA)
Amendment to the List of Psychotropic Substances (S.O. 1352(E)):
* Further amends the list of psychotropic substances specified in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
* Inserts the following substances into the Schedule:
* AB-CHMINACA
* 5F-ADB (5F-MDMB-PINACA)
* AB-PINACA
* UR-144
* 5F-PB22
* 4-Fluoroamphetamine (4FA)
Impact Analysis:
Government Agencies (e.g., Law Enforcement, Customs, Regulatory Bodies):
* Impact: These agencies are responsible for enforcing the regulations concerning narcotic drugs and psychotropic substances. The inclusion of these substances requires them to update their monitoring, detection, and enforcement strategies.
* Action Required: Update controlled substance lists, train personnel on identifying the new substances, and adjust enforcement procedures accordingly.
Pharmaceutical Industry, Chemical Manufacturers, and Research Institutions:
* Impact: These stakeholders must ensure compliance with the regulations regarding the handling, storage, and distribution of the newly controlled substances. This may affect research activities and product development.
* Action Required: Review internal procedures to ensure compliance with the updated regulations, obtain necessary licenses or permits, and implement appropriate security measures.
Healthcare Professionals:
* Impact: Healthcare professionals need to be aware of the inclusion of these substances, especially regarding potential abuse and misuse.
* Action Required: Update knowledge of controlled substances, exercise caution when prescribing or handling related medications (if applicable), and report any suspicious activities.
Key Entities Referenced
Narcotic Drugs and Psychotropic Substances Act, 1985: An Indian law to consolidate and amend the laws relating to narcotic drugs, to make stringent provisions for the control and regulation of operations relating to narcotic drugs and psychotropic substances.
Central Government: The executive authority of the Union of India.
Ministry of Finance: A ministry in the Government of India responsible for the country's finances and economy.
Department of Revenue: Part of the Ministry of Finance in the Government of India. It controls the collection of direct and indirect taxes through its various arms.
New Delhi: The capital of India, where the notification was issued.
Carfentanil: A highly potent synthetic opioid, declared as a manufactured drug in the notification.
Ocfentanil: A synthetic opioid, declared as a manufactured drug in the notification.
United Nations Convention on Psychotropic Substances 1971: An international treaty designed to control psychotropic substances such as amphetamines, barbiturates, and hallucinogens.
jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99
vlk/kj.k
EXTRAORDINARY
Hkkx II—[k.M 3—mi&[k.M (ii)
PART II—Section 3—Sub-section (ii)
izkf/dkj ls izdkf'kr
PUBLISHED BY AUTHORITY
la- 1207] ubZ fnYyh] cq/okj ekpZ 13] 2019@iQkYxqu 22] 1940
No.1207] NEW DELHI, WEDNESDAY, MARCH 13, 2019/PHALGUNA 22, 1940
ििििवववव(cid:3)(cid:3)(cid:3)(cid:3) मममम(cid:4)(cid:4)ंं(cid:4)(cid:4)ंं ााााललललयययय
((((ररररााााजजजज(cid:4)(cid:4)(cid:4)(cid:4)वववव ििििववववभभभभाााागगगग))))
अअअअििििधधधधससससचचूूचचूू ननननाााा
नई (cid:1)द(cid:3)ली, 13 ekpZ, 2019
ककककाााा....आआआआ.... 1111333355550000((((अअअअ))))....———— क(cid:7)(cid:8) सरकार, (cid:9) वापक औषिध और मन:(cid:13)भावी पदाथ (cid:17) अिधिनयम, 1985 (1985 का 61) क(cid:18)
धारा 2 के ख(cid:21)ड (xi) के उप-ख(cid:21)ड (ख) (cid:23)ारा (cid:13)द(cid:25) त शि(cid:29)त य(cid:31) का (cid:13)योग करते "ए, एतत(cid:23)ारा िन%म(cid:17)त औषिध के िलए
िन’न िलिखत पदाथ(, सा(cid:3)* स और इसक(cid:18) साम-ी क(cid:18) घोषणा करती ह,ै अथा(cid:17)त:् -
(i) कारफ(cid:7)टािनल: मथे ाइल 1-(2-फेनी लेथाइल)-4-[फेनाइल((cid:13)ोपनाइल)अमीनो]पाइपरे ीडाइन-4-कारबॉ(cid:29)स ीलेट;
(ii) ऑ(cid:29)फ े:ट ािनल:एन-(2-;लूओरोफेनाइल)-2-मथे ॉ(cid:29) सी-एन-[1-(2-फेनाइलथे ाइल)पाइपरे ीिडन-4-l]एसेटामाइड;
(iii) ;यूरनाइलफ(cid:7)टानाइल:एन-फेनाइल-एन-[1-(2-फेनाइलेथाइल)पाइपेरीिडन-4-यल];यूरान-2-कारबॉ(cid:29)स ामाइड;
(iv) ए(cid:1)>लॉइलफ(cid:7)टानाइल(ए(cid:1)>लफ(cid:7)टानाइल):एन-फेनाइल-एन-[1-(2-फेनाइलेथाइल) पाइपेरीिडन -4-यल](cid:13)ोप-2-
एनामाइड;
(v) 4-;लूओरॉयसोब य् ूटायरफ(cid:7)टानाइल:एन-(4-;लओू रोफेनी)-2-मथे ाइल-एन-[1-(2- फेनाइलेथाइल) पाइपरे ीिडन -4-
यल](cid:13)ोपने ामाइड;
(vi) टे?ाहाइ@ो;यरू ानाइलफ(cid:7)टानाइल:एन-फेनाइल-एन-[1-(2-फेनाइलेथाइल)पाइपेरीिडन-4-यल]ऑ(cid:29) सोलेन-2-
कारबॉ(cid:29)स ामाइड ।
[फा.स.ं एन-11011/1/2018-एनसी-II]
टी.के सतपथी, अवर सिचव
1710 GI/2019 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
MINISTRY OF FINANCE
(Department of Revenue)
NOTIFICATION
New Delhi, the 13th March, 2019
S.O. 1350(E).—In exercise of the powers conferred by sub-clause (b) of clause (xi) of section 2 of the
Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby declares
the following substances, salts and preparations thereof to be manufactured drugs, namely: —
(i) Carfentanil: Methyl 1-(2-pheny lethyl)-4-[phenyl(propnoyl)amino]piperidine-4-carboxylate;
(ii) Ocfentanil: N-(2-Fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-l]acetamide;
(iii) Furanylfentanyl: N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-y1]furan-2-carboxamide;
(iv) Acryloylfentanyl (Acrylfentanyl): N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-y1]prop-2-enamide;
(v) 4-Fluoroisobutyrfentanyl:N-(4-Fluoropheny)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-
yl]propenamide;
(vi) Tetrahydrofuranylfentanyl: N-Phenyl-N-[1-(2-phenylethy)piperidin-4-yl]oxolane-2-carboxamide.
[F. No. N-11011/1/2018-NC-II]
T.K. SATPATHY, Under Secy.
अअअअििििधधधधससससचचूूचचूू ननननाााा
नई (cid:1)द(cid:3)ली, 13 ekpZ, 2019
ककककाााा....आआआआ.... 1111333355551111((((अअअअ))))....———— क(cid:2)(cid:3) सरकार, (cid:4)व ापक औषिध और मन:(cid:8)भावी पदाथ (cid:14) अिधिनयम, 1985(1985 का
61) क(cid:15) धारा 2 के ख(cid:17)ड (viiक) और (xxiiiक) (cid:19)ारा (cid:8)दत ् शि(cid:25)त य(cid:27) का (cid:8)योग करत े (cid:30)ए, एत ारा सं#य ा का.आ.
1055 (अ) $दनांक 19 अ(cid:25) तबू र, 2001 के तहत भारत के राजप), भाग II, ख(cid:17)ड 3 उप-ख(cid:17)ड (ii) म(cid:2) (cid:8)कािशत,
भारत सरकार, िव+ त म)ं ालय, राज(cid:4) व िवभाग क(cid:15) अिधसूचना म (cid:2) िन-न िलिखत और आगे संशोधन करती ह,ै अथा(cid:14)त:्
उ(cid:25) त अिधसूचना म(cid:2), तािलका म(cid:2), /म सं#य ा 238ZH और इससे सबं 1 (cid:8)िवि2य(cid:27) के प3च ात् िन- निलिखत
/म सं#य ाए ं और (cid:8)िवि2य(cid:27) का समावेशन $कया जाएगा, अथा(cid:14)त:् —
(cid:1)(cid:1)(cid:1)(cid:1).... ससससंं..ंं.. (cid:2)(cid:2)(cid:2)(cid:2)वव व व ाााापपपपकककक औऔऔऔषषषषििििधधधध औऔऔऔरररर अअअअ(cid:22)(cid:22)(cid:22)(cid:22)यय यय गगगगैरैरैरैर----(cid:2)(cid:2)(cid:2)(cid:2)ववववााााििििमममम(cid:21)(cid:21)(cid:21)(cid:21)वववव ररररससससााााययययििििननननकककक ननननाााामममम अअअअ(cid:23)(cid:23)(cid:23)(cid:23)पप पप ममममाााा(cid:24)(cid:24)(cid:24)(cid:24)ाााा ववववााााििििणणणणिििि(cid:27)(cid:27)(cid:27)(cid:27)ययययकककक
ममममनननन::::(cid:6)(cid:6)(cid:6)(cid:6)भभभभााााववववीीीी पपपपददददााााथथथथ (cid:12)(cid:12) (cid:12)(cid:12) ननननाााामममम (((((cid:25)(cid:25)(cid:25)(cid:25)ाााा.... मममम))(cid:26)(cid:26)))(cid:26)(cid:26) ममममाााा(cid:24)(cid:24)(cid:24)(cid:24)ाााा
(अअअअततंंततंं रररराााा(cid:17)(cid:17)(cid:12)(cid:12)(cid:17)(cid:17)(cid:12)(cid:12) ीीीीयययय गगगगररैैररैै ----(cid:2)(cid:2)(cid:2)(cid:2)ववववााााििििमममम(cid:21)(cid:21)(cid:21)(cid:21)वववव (((((cid:25)(cid:25)(cid:25)(cid:25)ाााा....////(cid:29)(cid:29)(cid:29)(cid:29)कककक(cid:25)(cid:25)(cid:25)(cid:25)ाााा....))))
ननननाााामममम ((((आआआआईईईईएएएएननननएएएएनननन)) ककककाााा
ननननाााामममम
1111 2222 3333 4444 5555 6666
“238ZI कारफ(cid:5)टािनल मेथाइल 1-(2-फेनी लेथाइल)-4- 0.005 0.1(cid:20)ाम;
[फेनाइल((cid:10)ोपनॉइल)अमीनो]पायपरी (cid:20)ाम
डाइन-4-कारबॉ(cid:16)सीलेट
238ZJ ऑफ(cid:5)टािनल एन-(2-(cid:23)लूओरोफेनाइल)-2-मेथा(cid:16) सी- 0.005(cid:20)ाम 0.1(cid:20)ाम;
एन-[1-(2-फेनाइलेथाइल)पाइपरीिडन-
4-l]एकेटेमाइड
238ZK फुरानाइलफ(cid:5)टानाइल एन-(cid:29)फनाइल-एन-[1-(2- 0.005(cid:20)ाम 0.1(cid:20)ाम;
(cid:29)फनाइलेथाइल)पाइपेरीडाइन-4-
यल]फुरान-2-कारबॉ(cid:16) सामाइड¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 3
238ZL ए(cid:31) लॉइलफेनटानाइल ए(cid:31)ाइलफे! टानाइल एन-(cid:29)फनाइल-एन-[1-(2- 0.005(cid:20)ाम 0.1(cid:20)ाम;
(cid:29)फनाइलेथाइल) पाइपेरीडाइन-4-
वाई1](cid:10)ोप-2-एनामाइड
238ZM 4-(cid:23)लूओरोआइसोबुटायर 4-एफआईबीएफ, एन-(4-(cid:23)लूओरोफेनी)-2-मेथाइल-एन- 0.005(cid:20)ाम 0.1(cid:20)ाम;
फ(cid:5)टानाइल पीएफआईबीएफ [1-(2- (cid:29)फनाइलेथाइल) पाइपेरीडाइन-
4-यल](cid:10)ोपेनामाइड;
238ZN टे(cid:3)ाहाइ(cid:7)ो(cid:9)यूरानाइलफ(cid:16)टाइ टीएचएफ एन-फेनाइल-एन-[1-(2- 0.005(cid:20)ाम 0.1(cid:20)ाम;
ल
(cid:29)फनाइलेथाइल) पाइपेरीडाइन-4-
यल]ऑ(cid:16) सोलेन-2-कारबॉ(cid:16) सामाइड
238ZO एबी- एन-[(2S)-1-अमीनो-3-मेथाइल-1- 2(cid:20)ाम 50(cid:20)ाम;
सीएचएमआईएनएसीए आफ(cid:16) सोबुटान-2-यल]-1-
(साइ(cid:16) लोहिे(cid:16)स& मेथाइल)-1एच-
इंडाज़ोल-3-काबॉ(cid:16) सामाइड
238ZP 5एफ-एडीबी (5एफ- मेथाइल(2एस)-2-{1-(5- 2(cid:20)ाम 50(cid:20)ाम;
एमडीएमबी- (cid:23)लूओरोफ(cid:5)टाइल)-1एच-इंडाज़ोल-3-
पीआईएनएसीए) कारबोनाइलअमीनो}-3,3-
डाइिमथाइलबुटानोएट
238ZQ एबी-पीआईएनएसीए एन-[(2S)-1-अमीनो-3-मेथाइल- 2(cid:20)ाम 50(cid:20)ाम;
1ऑ(cid:16) सोबुटान-2यल]-1-प(cid:5)टाइल एच-
इंडाज़ोल 3-कारबॉ(cid:16) सामाइड
238ZR यूआर-144 (1-पे! टी-1एच-इंडोल-3- 2(cid:20)ाम 50(cid:20)ाम;
यल)(2,2,3,3-
टे(ामरथाइलसा(cid:16) लो(cid:10)ोफाइ)मेथानोन
238ZS 5F-पीबी-22 (cid:16) वीनोिलन-8-यल 1-(5- 2(cid:20)ाम 50(cid:20)ाम;
(cid:23)लूरोपेि!थल)-1एच-इंडोल-3-
कारबॉि(cid:16)सलेट
238ZT 4-(cid:23)लूओरोएमफेटामाइन 4-एफए 1-(4-(cid:23)लूरोफेनाइल) (cid:10)ोपन-2-अमीनो 2(cid:20)ाम 50(cid:20)ाम”.
[फा.सं. एन-11011/1/2018-एनसी.II]
टी.के.सतपथी ,अवर सिचव
(cid:6)(cid:6)(cid:6)(cid:6)टटटट(cid:8)(cid:8)(cid:8)(cid:8)पप पप णणणणीीीी: मुBय अिधसूचना सBं य ा का.आ. 1055 (अ), (cid:1)दनाकं 19 अ(cid:29) तूबर, 2001 के तहत,भारत के राजपE, भाग II, ख(cid:21) ड
3, उप-ख(cid:21)ड (ii) म(cid:7) (cid:13)कािशत (cid:1)कया गया था और त(cid:25)पF चात् सBं या का.आ. 2941 (अ), (cid:1)दनाकं 18 नव’ बर, 2009,
का.आ. 1430 (अ), (cid:1)दनाकं 21st जून, 2011,का.आ. 375 (अ) (cid:1)दनाकं 5 फरवरी, 2015, का. आ. 2375(अ),
(cid:1)दनाकं 12 जुलाई, 2016, का.आ. 384 (अ), (cid:1)दनाकं 2 मई, 2017, का.आ. 822(अ), (cid:1)दनाकं 27 फरवरी, 2018
और का.आ. 1762(अ), (cid:1)दनाकं 26 अ(cid:13)ैल, 2018 के तहत सशं ोिधत (cid:1)कया गया था ।
NOTIFICATION
New Delhi, the 13th March, 2019
S.O. 1351(E).—In exercise of the powers conferred by clauses (viia) and (xxiiia) of section 2 of the
Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby makes
the following further amendments in the notification of the Government of India, Ministry of Finance,4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Department of Revenue, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii)
vide number S.O. 1055 (E), dated the 19th October, 2001, namely: —
In the said notification, in the Table, after serial number 238 ZH and the entries relating thereto, the
following serial numbers and entries shall be inserted, namely: —
S. No. Name of Narcotic Drug Other non- Chemical Name Small Commercial
and Psychotropic proprietary Quantity Quantity
Substance name (in gm.) (in gm./ kg.)
(International non-
proprietary name (INN))
1 2 3 4 5 6
“238ZI Carfentanil Methyl 1-(2-pheny lethyl)-4- 0.005 gm 0.1 gm;
[phenyl(propnoyl)amino]piperidine-
4-carboxylate
238 ZJ Ocfentanil N-(2-Fluorophenyl)-2-methoxy-N- 0.005 gm 0.1 gm;
[1-(2-phenylethyl)piperidin-4-
l]acetamide
238 Furanylfentanyl N-Phenyl-N-[1-(2- 0.005 gm 0.1 gm;
ZK phenylethyl)piperidin-4-y1]furan-2-
carboxamide
238 ZL Acryloylfentanyl Acrrylfentan- N-Phenyl-N-[1-(2- 0.005 gm 0.1 gm;
yl phenylethyl)piperidin-4-y1]prop-2-
enamide
238ZM 4-Fluoroisobutyrfentanyl 4-FIBF, N-(4-Fluoropheny)-2-methyl-N-[1- 0.005 gm 0.1 gm;
pFIBF (2-phenylethyl)piperidin-4-
yl]propenamide;
238 Tetrahydrofuranylfentanyl THF N-Phenyl-N-[1-(2- 0.005 gm 0.1 gm;
ZN phenylethy)piperidin-4-yl]oxolane-
2-carboxamide
238 AB- N-[(2S)-1-Amino-3-methyl-1- 2 gm 50 gm;
ZO CHMINACA oxobutan-2-yl]-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide
238 ZP 5F-ADB Methyl(2S)-2-{1-(5-fluorophentyl)- 2 gm 50 gm;
(5F-MDMB- 1H-indazole-3-carbonylamino}-3,3-
PINACA) dimethylbutanoate
238 AB-PINACA N-[(2S)-1-Amino-3-methyl- 2 gm 50 gm;
ZQ 1oxobutan-2yl]-1-penty1H-indazole
3-carboxamide
238 UR-144 (1-Penty-1 H-indol-3- yl) (2,2,3,3- 2 gm 50 gm;
ZR tetramrthylcyclopropyl)methanone
238 ZS 5F-PB-22 Quinolin-8-yl 1-(5-fluropenthl)-1h- 2 gm 50 gm;
inodole-3-carboxylate
238 ZT 4-Fluoroamphetamine 4-FA 1-(4-Fluorophenyl) propan-2-amine 2 gm 50 gm”.
[F. No. N-11011/1/2018-NC. II]
T.K. SATPATHY, Under Secy.
Note: The principal notification was published in the Gazette of India, Extraordinary, Part II, Section
3, Sub-section (ii), vide number S.O. 1055 (E), dated the 19th October, 2001 and subsequently
amended vide numbers S.O. 2941 (E), dated the 18th November, 2009, S.O. 1430 (E), dated
the 21st June, 2011, S.O. 375 (E) dated the 5th February, 2015, S. O. 2375(E), dated the 12th
July, 2016, S.O. 384 (E), dated the 2nd May, 2017, S.O. 822(E), dated the 27th February, 2018
and S.O. 1762(E), dated the 26th April, 2018.¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 5
अअअअििििधधधधससससचचूूचचूू ननननाााा
नई (cid:1)द(cid:3)ली, 13 ekpZ, 2019
ककककाााा....आआआआ.... 1111333355552222((((अअअअ))))....———— जब$क क(cid:2)(cid:3) सरकार, जानकारी और (cid:8)माण(cid:27), जो इसके िलए उपल6ध हो गया ह,ै (cid:8)कृित
और (cid:8)भाव के सबं ंध म (cid:2) और िन9िलिखत पदाथ: ((cid:8)ाकृितक या ;संथे=टक) या (cid:8)ाकृितक साम?ी या $कसी भी सा@ट
या इसके दBु पयोग क(cid:15) गुंजाइश के आधार पर ऐसे पदाथ: या सामि?य(cid:27) क(cid:15) तैयारी, और ऐसे पदाथ: के सबं ंध म(cid:2)
संशोधन और मन:(cid:8)भावी पदाथ: पर संयुC राD के कEव(cid:2)शन 1971 म(cid:2) शािमल $कए गए बदलाव, $क िन9िलिखत
पदाथ: या (cid:8)ाकृितक सामि?य(cid:27) या सा@ Fस को जोड़ना आव3यक ह ै या ऐसी तैयारी मादक पदाथ: क(cid:15) सूची म (cid:2) पदाथ(cid:14)
या ऐसी साम?ी के आधार पर संतुH ट ह ै जो (cid:4)व ापक औषिध और मन:(cid:8)भावी पदाथ (cid:14) अिधिनयम, 1985 (1985 के
61) (एति3मनप3 चात ् उC अिधिनयम के Iप म (cid:2) यथा सदं Jभ(cid:14)त) क(cid:15) अनुसचू ी म (cid:2) िनKद2(cid:14) ह;ै
अत:, अब, उC अिधिनयम क(cid:15) धारा 3 (cid:19)ारा (cid:8)दL शिCय(cid:27) का (cid:8)योग करत े (cid:30)ए, क(cid:2)(cid:3) सरकार एत ारा उC
अिधिनयम क(cid:15) अनुसचू ी म (cid:2) िविनKद2(cid:14) मन:(cid:8)भावी पदाथ: क(cid:15) सूची म (cid:2) िन9िलिखत संशोधन करती ह,ै अथा(cid:14)त ् :-
उC अिधिनयम म(cid:2), अनुसूची म,(cid:2) /म सं#या 110Y और इससे सबं ंिधत (cid:8)िवि2य(cid:27) के प3च ात,् िन9िलिखत
/म सं#य ा और (cid:8)िवि2य(cid:27) को समावेिशत $कया जाएगा, अथा(cid:14)त:्-
(cid:31). सं. अंतरा-.ट ीय गैर-/व ािम0व अ! य गैर-/ वािम0 व नाम रसायिनक नाम
नाम
“110Z एबी-सीएचएमआईएनएसीए एन-[(2S)-1-अमीनो-3-िमथाइल-1-ऑ(cid:16) सोबटन-2-
यल]-1-(साइकोहिै(cid:16) सलिमथाइल)-1एच-इंडाज़ोल-3-
कारबॉ(cid:16) सामाइड
110ZA 5एफ-एडीबी (5एफ- िमथाइल(2एस)-2-{1-(5-(cid:23)लूओरोफे! टाइल)-1एच-
एमडीएमबी-परइाद3 एनएसीए) इंडाज़ोल-3-काब4नाइलअमीनो}-3,3-
डायिमथाइलबुटानोएट
110ZB एबी-पीआईएनएसीए एन-[(2S)-1-अमीनो-3-िमथाइल-1ऑ(cid:16) सोबुटान-
2यल]-1-पेनटी1एच-इंडाज़ोल 3-काबॉ(cid:16) सामाइड
110ZC यूआर-144 (1-पे! टी-1एचव-इंडोल-3-यल)(2,2,3,3-
टे(ामरथाइलसाइ(cid:16) लो(cid:10)ोफाइल)मेथानोन
110ZD 5एफ-पीबी-22 (cid:29)5नोिलन-8-yl1-(5-(cid:23)जलूरोपेनथाइल)-1एच-
इनोडोल-3-कारबॉ(cid:16) सीलेट
110ZE 4-(cid:23)लूओरोमफेटामाइन 4-एफए 1-(4-फलूओरोफेनाइल) (cid:10)ेपान-2-अमीनो”।
[फा. स.ं एन-11011/1/2018-एनसी. ]
II
टी.के सतपथी, अवर सिचव
(cid:6)(cid:6)(cid:6)(cid:6)टटटट(cid:8)(cid:8)(cid:8)(cid:8)पप पप णणणणीीीी: (cid:9)व ापक औषिध और मन:(cid:13)भावी पदाथ (cid:17) अिधिनयम, 1985 (1985 के 61) हते ु अनसु ूची को सBं या का.आ. 785(अ)
(cid:1)दनाकं 26 अ(cid:29)त ूबर, 1992 के तहत (cid:13)थम सशं ोिधत (cid:1)कया गया था और त (cid:25)पF चात् सBं या का.आ. 49(अ), (cid:1)दनाकं
8 जनवरी, 1993, का.आ. 39(अ), (cid:1)दनाकं 12 जनवरी, 1996, का.आ. 475(अ), (cid:1)दनाकं 11 जून, 2003,
सा.का.िन. 621(अ), (cid:1)दनाकं 1 अग(cid:9) त, 2003, सा.का.िन. 1(अ), (cid:1)दनाकं 2 जनवरी, 2004, का. आ. 311 (अ),
(cid:1)दनाकं 10 फरवरी, 2011, का. आ. 376 (अ), (cid:1)दनाकं 5 फरवरी, 2015, का. आ. सं0. 2374 (अ), (cid:1)दनाकं 12
July, 2016, का.आ. सं0. 1383 (अ), (cid:1)दनाकं 2 May, 2017, का.आ. 821(अ), (cid:1)दनाकं 27 फरवरी, 2018,
का.आ. 1761(अ), (cid:1)दनाकं 26 अ(cid:13)ैल, 2018 और का.आ. 3448(अ) (cid:1)दनाकं 13 जुलाई, 2018 के तहत सशं ोिधत
(cid:1)कया गया ।6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
NOTIFICATION
New Delhi, the 13th March, 2019
S.O. 1352(E).— Whereas the Central Government is satisfied, on the basis of information and
evidence which has become available to it, with respect to the nature and effect of and the scope for abuse of
the following substances (natural or synthetic) or natural material or any salt or preparation of such substances
or materials, and the modification with respect to such substances and the changes that have been incorporated
in the United Nations Convention on Psychotropic Substances 1971, that it is necessary to add the following
substances or natural materials or salts or preparation of such substances or materials in the list of
psychotropic substances specified in the Schedule to the Narcotic Drugs and Psychotropic Substances Act,
1985 (61 of 1985) (hereinafter referred to as the said Act);
Now, therefore, in exercise of the powers conferred by section 3 of the said Act, the Central
Government hereby makes the following further amendments in the list of psychotropic substances specified
in the Schedule to the said Act, namely: —
In the said Act, in the Schedule, after serial number 110 Y and the entries relating thereto, the
following serial numbers and entries shall be inserted, namely: —
SI. International Other Chemical name
No. non-proprietary non-proprietary names
names
“110Z AB-CHMINACA N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-
(cyclohexylmethyl)-1H-indazole-3-carboxamide
110ZA 5F-ADB (5F-MDMB- Methyl(2S)-2-{1-(5-fluorophentyl)-1H-indazole-3-
PINACA) carbonylamino}-3,3-dimethylbutanoate
110ZB AB-PINACA N-[(2S)-1-Amino-3-methyl-1oxobutan-2yl]-1-penty1H-
indazole 3-carboxamide
110ZC UR-144 (1-Penty-1 H-indol-3-yl) (2,2,3,3-tetramrthylcyclopropyl)
methanone
110ZD 5F-PB-22 Quinolin-8-yl 1-(5-fluropenthl)-1h-inodole-3-carboxylate
110ZE 4-Fluoroamphetamine 4-FA 1-(4-Fluorophenyl) propan-2-amine”.
[F. No. N-11011/1/2018-NC. II]
T.K. SATPATHY, Under Secy
Note: The Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985) was first amended vide
number S.O. 785(E), dated the 26th October, 1992 and subsequently amended vide numbers S.O. 49(E), dated
the 8th January, 1993, S.O. 39(E), dated the 12th January, 1996, S.O. 475(E), dated the 11th June, 2003, G.S.R.
621(E), dated the 1st August, 2003, G.S.R. 1(E), dated the 2nd January, 2004, S. O. 311 (E), dated the
10th February, 2011, S. O. 376 (E), dated the 5th February, 2015, S. O. No. 2374 (E), dated the 12th July, 2016,
S.O. No. 1383 (E), dated the 2nd May, 2017, S.O. 821(E), dated the 27th February, 2018, S.O. 1761(E), dated
the 26th April, 2018 and S.O. 3448(E) dated the 13th July, 2018.
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.